By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cellerant Therapeutics, Inc. 

1531 Industrial Road

San Carlos  California  94070  U.S.A.
Phone: 650-232-2122 Fax: 650-232-5495


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
Cellerant Therapeutics, Inc. Announces Timothy Fong As Vice President Of Cellular Technologies And Jagath Reddy Junutula As Vice President Of Antibody Discovery & Development 5/12/2014 7:17:29 AM
Cellerant Therapeutics, Inc. Awarded SBIR Contract Funding to Develop CLT-009 for Treatment of Thrombocytopenia 10/8/2012 9:52:09 AM
Cellerant Therapeutics, Inc. Awarded $36.4 Million Option Under Existing U.S. Government Contract to Support Development of CLT-008 for Treatment of Acute Radiation Syndrome 9/4/2012 10:02:48 AM
Cellerant Therapeutics, Inc. to Present at the International Society for Stem Cell Research 10th Annual Meeting in Japan 6/15/2012 10:23:37 AM
Cellerant Therapeutics, Inc. Appoints Gisela Schwab, M.D., to Its Board of Directors and Names Lowell Sears as Chairman of the Board 6/15/2012 10:06:24 AM
Cellerant Therapeutics, Inc. Announces Publication Demonstrating Significant Survival Benefits and Preclinical Proof of Concept With Myeloid Progenitors as Radiation Countermeasure 5/14/2012 10:14:37 AM
Cellerant Therapeutics, Inc. Appoints Lowell E. Sears to Board of Directors 2/21/2012 7:26:29 AM
Cellerant Therapeutics, Inc. Awarded Additional $16.7 Million From US Government 9/15/2011 7:37:33 AM
Cellerant Therapeutics, Inc. Initiates a Phase I/II Clinical Trial of CLT-008 for Chemotherapy Induced Neutropenia in Acute Leukemia Patients 3/22/2011 8:22:37 AM
Cellerant Therapeutics, Inc. Announces Key Additions to Sr. Management Team 2/7/2011 8:07:06 AM
123
//-->